Intestinal inflammation and the gut microflora

Canadian Journal of Gastroenterology

Volumn 13, Issue 6, 1999, Pages 509-516

  McKay, Derek M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Gut inflammation; Inflammatory bowel disease; Microflora

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE;

ANTIBIOTIC THERAPY; CROHN DISEASE; ENTERITIS; HUMAN; INTESTINE FLORA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0032833261     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/680206     Document Type: Review

References (110)

1. Abrams G. Microbial effects on mucosal structure and function. Am J Clin Nutr 1977;30:1880-6.
2. Savage D. Gastrointestinal microflora in mammalian nutrition. Ann Rev Nutr 1986;6:155-78.
3. Rook GAW, Stannford JL. Give us this day our daily germs. Immunol Today 1998;19:113-6.
4. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
5. Sartor RB. The role of enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 1997;11(Suppl 3):17-23.
6. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
7. Sadlack B, Marz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin 10 deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
9. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-71.
10. + T cells, but not B cells, mediate colitis in interleukin 10 deficient mice. J Exp Med 1996;184:241-51.
11. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 1998;161:3141-51.
12. Ma A, Datta M, Margosian E, Chen J, Horak I. T cells, but not B cells, are required for bowel inflammation in interleukin-2 deficient mice. J Exp Med 1995;182:1567-72.
13. + T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2617-25.
14. + T cells. J Exp Med 1996;183:2669-74.
15. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998;161:5733-44.
16. Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adrenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992;33:1521-7.
17. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in induction of reliable experimental acute and chronic colitis in mice. Gastroenterology 1990;98:694-702.
18. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998;187:855-64.
19. Taurog J, Richardson J, Croft J, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
20. 2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
21. Garcia-Lafuente A, Antolin M, Guarner F, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997;272:G10-5.
22. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Zumbuschenfelde KHM. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1996;102:448-55.
23. Pirzer U, Schonhaar A, Fleischer B, Hermann E, Zumbuschenfelde KHM. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991;338:1238-9.
24. Duchmann R, Marker-Hermann E, Meyer zum Buschenfelde KH. Bacteria-specific T cell clones are selective in their reactivity towards different enterobacterta or H. pylori and increased in inflammatory bowel disease. Scand J Immunol 1996;44:71-9.
25. Duchmann R, Schmitt E, Knolle P, Zumbuschenfelde KHM, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26:934-8.
26. Mizoguchi A, Mizoguchi E, Chiba C, et al. Cytokine imblance and autoantibody production in TCR-α-/- mice with inflammatory bowel disease. J Exp Med 1996;183:847-56.
27. Mizoguchi A, Mizoguchi E, Chiba, Balk AK. Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J Exp Med 1996;184:707-15.
28. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstein RJ. On the etiology of Crohn's disease. Proc Natl Acad Sci USA 1996;93:9816-20.
29. Rowbotham D, Howdle P, Trejdosiewicz L. Peripheral cell mediated immune response to mycobacterial antigens in inflammatory bowel disease. Clin Exp Immunol 1995;102:456-61.
30. Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997;65:3126-31.
31. Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bids-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 1997;65:4858-64.
32. Weber P, Kock M, Heizmann WR, Scheulen M, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1998;1992:302-8.
33. Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985;89:587-95.
34. Klasen IS, Melief MJ, van Halteren AGS, et al. The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease. Clin Immunol Immunopathol 1994;71:303-8.
35. Hazenberg MP, de Visser H, Bras MJ, Prins ME, van de Merwe JP. Serum antibodies to peptidoglycan-polysaccharide complexes from the anaerobic intestinal flora in patients with Crohn's disease. Digestion 1990;47:172-80.
36. Chester JF, Ross JS, Malt RA, Weitzman SA. Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol 1985;121:284-90.
37. Anton PA, Targan SR, Shanahan F. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide-formyl-methionyl-leucyl-phenylalanine in Crohn's disease. Gastroenterology 1989;97:20-8.
38. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994;35:669-74.
39. Baldassano RN, Schreiber S, Johnston RB, Fu RD, Muraki T, MacDermott RP. Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 1993;105:60-6.
40. Webb SR, Gascoigne NRJ. T cell activation by superantigens. Curr Opin Immunol 1994;6:467-75.
41. Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 1996;212:99-109.
42. Blackman MA, Woodland DL. In vivo effects of superantigens. Life Sci 1995;57:1717-35.
43. Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
44. Conrad B, Weldmann E, Trucco G, et al. Evidence for superantigen involvement in insulin dependent diabetes mellitus aetiology. Nature 1994;371:351-5.
45. Curtis N, Zheng R, Lamb Jr, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Childhood 1995;72:308-11.
46. Brocke S, Hausmann S, Steinman L, Wucherpfennig KW. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin Immunol 1998;10:57-67.
47. + T cells in Crohn's disease. J Clin Invest 1990;85:1770-6.
48. Gulwani-Akolkar B, Akolkar PN, Minassian A, et al. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J Clin Invest 1996;98:1344-54.
49. Ogawa H, Ito K, Takeda H, et al. Universal skew of T cell receptor (TCR) Vb usage for Crohn's disease. Biochem Biophys Res Comm 1997;240:545-51.
50. Kay RA. The potential role of superantigens in inflammatory bowel disease. Clin Exp Immunol 1995;100:4-6.
51. van Prohaska J. Role of staphylococcal enterotoxin in the induction of experimental ileitis. Ann Surgery 1963;158:492-7.
52. Kent TH. Staphylococcal enterotoxin gastroenteritis in Rhesus monkeys. Am J Pathol 1965;48:387-407.
53. Merrill T, Sprinz H. The effect of staphylococcal enterotoxin on the fine structure of the monkey jejunum. Lab Invest 1968;18:114-23.
54. + T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol 1993;23:664-8.
55. McKay DM, Donnelly G, Takeda T. Immune activation by Yersinia pseudotuberculosis mitogen (YPM) causes increased epithelial permeability and is prevented by inhibition of prostaglandin synthesis. J Allergy Clin Immunol 1998;101:S192. (Abst)
56. 2. J Immunol 1997;159:2382-90.
57. Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang P, McKay DM. Epithelial transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by IL-10, but not IL-4. J Pharmacol Exp Ther 1998;287:128-36.
58. + T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol 1998;275:G29-38.
59. + T cells. Infect Immun 1998;66:2193-9.
60. Steiner TS, Lima AA, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 1998;177:88-96.
61. McKay DM, Baird AW. Cytokine regulation of epithelial permeability and ion transport. Gut 1999;44:283-9.
62. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1998;100:6-10.
63. Fiocchi C. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 1997;273:G769-75.
64. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-99.
65. Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267:G151-65.
66. Eckmann L, Reed S, Smith J, Kagnoff M. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1α. J Clin Invest 1995;96:1269-79.
67. Jung HC, Echmann L, Yang S, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
68. Casola A, Estes MK, Crawford SE, et al. Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology 1998;114:947-55.
69. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG, Szabo C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998;114:93-102.
70. Savkovic SD, Koutsouris A, Hecht G. Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect Immun 1996;64:4480-7.
71. Huang GT-J, Eckmann L, Savidge TC, Kagnoff MF. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J Clin Invest 1996;98:572-83.
72. + T cell activation during Helicobacter pylori infection. J Clin Invest 1997;99:1629-36.
73. Ismaili A, Philpott DJ, McKay DM, Perdue MH, Sherman PM. Epithelial cell responses to shiga toxin-producing Escherichia coli infection. In: Kaper JB, O'Brien AD, eds. Excherichia coli 0157:H7 and Other Shiga Toxin-Producing E. coli Strains. Washington: American Society for Microbiology, 1998:213-25.
74. Philpott DJ, McKay DM, Sherman PM, Perdue MH. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 1996;270:G634-45.
75. Spitz J, Yuhan R, Koutsouris A, Blatt C, Alverdy J, Hecht G. Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am J Physiol 1995;268:G374-9.
76. Stein MA, Mathers DA, Yan H, Baimbridge KG, Finlay BB. Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells. Infect Immun 1996;64:4820-5.
77. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finley BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997;91:511-20.
78. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988;82:1516-24.
79. 84 monolayers. Gastroenterology 1992;102:4416-23.
80. Fasano A, Baudry B, Pumplin D, Wasserman S, Tall B, Ketley J, Kaper J. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 1991;88:5242-6.
81. Wellis C, van de Westerlo E, Jechorek R, Feltis B, Wilkins T, Erlandsen S. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial intemalization by HT-29 enterocytes. Gastroenterology 1996;110:1429-39.
82. Mahida Y, Makh S, Hyde S, Gray T, Borriello S. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 1996;38:337-47.
83. Gustafson C, Kald B, Sjodahl R, Tagesson C. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet activating factor (PAF acether) in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 1991;26:1000-6.
84. Aisenberg J, Ebert EC, Mayer L. T cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology 1993;105:1421-30.
85. McKay DM, Philpott DJ, Perdue MH. In vitro models in inflammatory bowel disease research -a critical review. Aliment Pharmacol Ther 1997;11(Suppl3):70-80.
86. Philpott DJ, McKay DM, Mak W, Perdue MH, Sherman PM. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect Immun 1998;66:1680-7.
87. Ilnyckyj A, Greenberg H, Bernstein CN. Escherichia coli 0157:H7 infection mimicking Crohn's disease. Gastroenterology 1997;112:995-9.
88. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 1997;113:1099-109.
89. Ismaili A, Philpott D, Dytoc M, Sherman P. Signal transduction responses following adhesion of verocytotoxin producing Escherichia coli. Infect Immun 1995;63:3316-26.
90. Hobbie S, Chen LM, Davis RJ, Galan JE. Involvement of the mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 1997;159:5550-9.
91. Reinecker H, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706-13.
92. Brokenshire J, Botelho F, Richards CD, McKay DM. Mobilization of epithelial STAT-1 in response to mediators released from bacterial superantigen-activated immune cells. Gastroenterology 1998;114:A1131. (Abst)
93. Toy LS, Yio XY, Lin A, Honig S, Mayer L. Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest 1997;100:2062-71.
94. Watanabe M, Ueno Y, Tomoharu Y, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonie mucosa. J Exp Med 1998;187:389-402.
95. von Freeden-Jeffry U, Davidson N, Wiler R, Fort M, Burdach S, Murray R. IL-7 deficiency prevents development of a non-T cell non-B cell mediated colitis. J Immunol 1998;161:5673-80.
96. Watanabe M, Ueno Y, et al. Interleukin 7 is produced by human epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995;95:2945-53.
97. Yamada K, Shimaoka M, Nagayama K, Hiroi T, Kiyono H, Honda T. Bacterial invasion induces interleukin-7 receptor expression in colonie epithelial cell line, T84. Eur J Immunol 1998;27:3456-60.
98. Sutherland L, Singleton J, Sessions J, et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32:1071-5.
99. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
100. Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998;12:53-6.
101. Peppercorn MA. Antibiotics are effective therapy for Crohn's disease. Inflamm Bowel Dis 1997;3:318-9.
102. Feagan B. Antibiotics are not effective therapy for Crohn's Disease (time to remove the rose-colored glasses). Inflamm Bowel Dis 1997;3:314-7.
103. LaMont JT. Antibiotic associated diarrhea. Gastrointest Dis Today 1995;4:10-7.
104. Goldhill JM, Rose K, Percy WH. Effects of antibiotics on epithelial ion transport in the rabbit distal colon in vitro. J Pharm Pharmacol 1996;48:651-6.
105. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1983;83:383-7.
106. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
107. Lewis SJ, Freeman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998;12:807-22.
108. Malchow HA. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonie Crohn's disease? J Clin Gastroenterol 1997;25:653-8.
109. Bengmank S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2-7.
110. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116:1107-14.